Effect of different doses of remifentanil on stress response during laparoscopic cholecystectomy

J Opioid Manag. 2019 Jan/Feb;15(1):43-49. doi: 10.5055/jom.2019.0485.

Abstract

Objectives: An adequate perioperative analgesia reduces neuroendocrine stress response and postoperative complica-tions. Opioids are the most effective parenteral drugs to control pain and stress response.

Design: This is a prospective randomized double-blinded controlled study.

Setting: Institutional tertiary level.

Patients, participants: Fifty patients underwent general anesthesia with desflurane for laparoscopic cholecystectomy.

Main outcome measures: To compare two different doses of remifentanil (0.15 mcg/kg/min or 0.3 mcg/kg/min) in reducing markers of stress. Perioperative stress was assessed through the dosage of adrenocorticotropic hormone (ACTH), cortisol, growth hormone (GH), and prolactin (PRL). Three venous blood samples were collected from patients: before transferring the patient to the operating room (Time 0), at the trocar insertion (Time 1), and 1 hour after the end of the surgery (Time 2).

Results: Hemodynamic parameters showed no differences between the two groups. The authors observed an increase of GH and PRL in both groups at trocar insertion (Time 1) (p = 0.473 and 0.754, respectively). ACTH and cortisol showed a decrease at Time 1 and an increase after surgery (p = 0.586). The modification of stress parameters levels showed no significant differences between the two groups.

Conclusions: The results of our study showed that a lower dose of remifentanil is equally effective in controlling stress hormones during laparoscopic cholecystectomy.

MeSH terms

  • Analgesics, Opioid / therapeutic use*
  • Cholecystectomy, Laparoscopic* / adverse effects
  • Dose-Response Relationship, Drug
  • Hormones / blood
  • Humans
  • Prospective Studies
  • Remifentanil / therapeutic use*
  • Stress, Physiological / drug effects*

Substances

  • Analgesics, Opioid
  • Hormones
  • Remifentanil